ceFAZolin — Class II drug recall D-0896-2021
Terminated recall by IntegraDose Compounding Services LLC, reported 2021-10-06, distributed in MA, MN, NH. Lack of sterility assurance.
| Recall number | D-0896-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | IntegraDose Compounding Services LLC, Minneapolis, MN, United States |
| Recall initiated | 2021-09-17 |
| Classified | 2021-09-30 |
| Reported by FDA | 2021-10-06 |
| Terminated | 2022-10-02 |
| Distributed | MA, MN, NH |
| Quantity | 2,614 syringes |
| Reason classes | sterility |
| NDC | 71139-7087-01 |
| Lot numbers | 20210803CEF-1, 20210805CEF-3, 20210806CEF-1, 20210806CEF-2, 20210809CEF-1, 20210809CEF-2, 20210810CEF-1, 20210811CEF-1, 20210812CEF-1 |
| Expiration dates | 2021-09-17, 2021-09-20, 2021-09-23, 2021-09-24, 2021-09-25, 2021-09-26 |
Product
ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1
Reason for recall
Lack of sterility assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0896-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.